Jimin pharmaceutical shareholder Zhang Xueqin reduced 3.1999 million shares and cashed out 58.1397 million shares

On May 13, Jimin Pharmaceutical (603222) recently announced that Zhang Xueqin, the shareholder of the company, reduced 3.1999 million shares of the company by means of centralized bidding transaction. The price range of this reduction is 13.88-18.90 yuan / share, and the cash out is 58.1397 million yuan.

济民制药股东张雪琴减持319.99万股 套现5813.97万

According to the announcement, Zhang Xueqin held 39069200 shares of the company before the reduction, and 35869300 shares after the reduction, accounting for 10.53% of the total share capital.

According to the company’s report for the first quarter of 2021, the company’s net profit attributable to shareholders of Listed Companies in the first quarter of 2021 was 39943254.67 yuan, turning losses into profits over the same period of last year.

According to the data of digbei.com, Jimin pharmaceutical’s main business includes three business segments: R & D, production and sales of medical devices, medical service, and R & D, production and sales of infusion products.



邮箱地址不会被公开。 必填项已用*标注